Article | March 23, 2026

5 Costly Consequences Of FDA Non-Compliance – And How Your CMMS Can Help You Avoid Them

clinicla-trials-automation-GettyImages-2205446822

FDA citations trigger immediate consequences: public warning letters, lost contracts, investor concerns, and operational chaos. For pharmaceutical manufacturers and CDMOs, compliance failures stem from preventable maintenance gaps—missed calibrations, incomplete documentation, or overlooked work orders. Modern CMMS and EAM platforms transform compliance from a reactive scramble into a proactive system. Automated scheduling ensures critical maintenance never slips through the cracks, while digital audit trails provide instant access to timestamped calibration records and maintenance histories. Beyond avoiding 483s, these systems reduce downtime, streamline CAPA processes, and free teams from manual documentation tasks.

Learn how to quantify potential savings for your operation through a personalized cost-benefit analysis based on your asset count and work order volume.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online